Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study

Authors
Publication date
1 January 2017
Publisher
'Wiley'
Doi

    Abstract

    Item does not contain fulltex

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Radboud Repository

      redirect
      oaioai:repository.ubn.ru.nl:2066/...
      Last time updated on 11/04/2018

      NARCIS

      redirect
      Last time updated on 20/03/2018